Envista Holdings Corp Aktie News

Envista Holdings is upgraded from "Hold" to "Buy" ahead of its FY25 results, anticipating an earnings beat. Analyst forecasts appear overly conservative; NVST's cost optimization, share buybacks, and product traction suggest upside to consensus EPS. Recent investor events and sector surveys indicate strong momentum in implants, clear aligners, and diagnostic segments, with favorable market trends.

Envista Holdings Corporation (NVST) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

BREA, Calif., Jan. 8, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its fourth quarter 2025 on Thursday, February 5, 2026.

BREA, Calif., Jan. 7, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will present at the 44th Annual J.P.

Envista Holdings Corporation (NVST) Presents at Evercore 8th Annual Healthcare Conference Transcript

BREA, Calif. , Nov. 25, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the 8th Annual Evercore Healthcare Conference.

Envista Holdings Corporation ( NVST ) Q3 2025 Earnings Call October 30, 2025 5:00 PM EDT Company Participants Jim Gustafson - Vice President of Investor Relations Paul Keel - CEO & Director Eric Hammes - Senior VP & CFO Conference Call Participants Allen Lutz - BofA Securities, Research Division Elizabeth Anderson - Evercore ISI Institutional Equities, Research Division Michael Cherny - Leerink...

BREA, Calif. , Oct. 29, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the quarter ended September 26, 2025.